US Physical Therapy Inc has a consensus price target of $125.67 based on the ratings of 4 analysts. The high is $138 issued by B of A Securities on June 30, 2023. The low is $117 issued by JP Morgan on March 13, 2024. The 3 most-recent analyst ratings were released by Barrington Research, JP Morgan, and Barrington Research on May 9, 2024, March 13, 2024, and March 1, 2024, respectively. With an average price target of $120.33 between Barrington Research, JP Morgan, and Barrington Research, there's an implied 27.36% upside for US Physical Therapy Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/09/2024 | Buy Now | 29.13% | Barrington Research | Michael Petusky | $122 → $122 | Maintains | Outperform | Get Alert |
03/13/2024 | Buy Now | 23.84% | JP Morgan | Calvin Sternick | $99 → $117 | Maintains | Overweight | Get Alert |
03/01/2024 | Buy Now | 29.13% | Barrington Research | Michael Petusky | $120 → $122 | Maintains | Outperform | Get Alert |
01/03/2024 | Buy Now | 27.01% | Barrington Research | Michael Petusky | $111 → $120 | Maintains | Outperform | Get Alert |
11/17/2023 | Buy Now | 4.78% | JP Morgan | Calvin Sternick | $108 → $99 | Maintains | Overweight | Get Alert |
11/09/2023 | Buy Now | 17.49% | Barrington Research | Michael Petusky | $124 → $111 | Maintains | Outperform | Get Alert |
09/22/2023 | Buy Now | 14.31% | JP Morgan | Calvin Sternick | → $108 | Initiates | → Overweight | Get Alert |
09/19/2023 | Buy Now | — | CJS Securities | Larry Solow | — | Upgrade | Market Perform → Market Outperform | Get Alert |
08/14/2023 | Buy Now | 31.24% | Barrington Research | Michael Petusky | $116 → $124 | Maintains | Outperform | Get Alert |
06/30/2023 | Buy Now | 46.06% | B of A Securities | Joanna Gajuk | → $138 | Initiates | → Buy | Get Alert |
05/05/2023 | Buy Now | 22.78% | Barrington Research | Michael Petusky | $110 → $116 | Maintains | Outperform | Get Alert |
02/24/2023 | Buy Now | 16.43% | Barrington Research | Michael Petusky | $107 → $110 | Maintains | Outperform | Get Alert |
12/14/2021 | Buy Now | 27.01% | CJS Securities | Larry Solow | — | Upgrade | Market Perform → Market Outperform | Get Alert |
The latest price target for US Physical Therapy (NYSE:USPH) was reported by Barrington Research on May 9, 2024. The analyst firm set a price target for $122.00 expecting USPH to rise to within 12 months (a possible 29.13% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for US Physical Therapy (NYSE:USPH) was provided by Barrington Research, and US Physical Therapy maintained their outperform rating.
The last upgrade for US Physical Therapy Inc happened on September 19, 2023 when CJS Securities raised their price target to N/A. CJS Securities previously had a market perform for US Physical Therapy Inc.
There is no last downgrade for US Physical Therapy.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of US Physical Therapy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for US Physical Therapy was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
While ratings are subjective and will change, the latest US Physical Therapy (USPH) rating was a maintained with a price target of $122.00 to $122.00. The current price US Physical Therapy (USPH) is trading at is $94.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.